1. An Overview of Similarities and Differences in Metabolic Actions and Effects of Central Nervous System Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium Glucose Co-Transporter-2 Inhibitors (SGLT-2is)
   Song Wen et al, 2021, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy CrossRef
2. A meta-analysis evaluating indirectly GLP-1 receptor agonists and arrhythmias in patients with type 2 diabetes and myocardial infarction
   Zhijie Liu et al, 2022, Frontiers in Cardiovascular Medicine CrossRef